Entrada Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $47k | 3.1k | 15.09 |
| 2023-09-30 | $490 | 31 | 15.81 |
| 2023-03-31 | $899k | 62k | 14.50 |
| 2022-12-31 | $690k | 51k | 13.52 |
| 2022-09-30 | $25k | 1.6k | 15.79 |
| 2021-12-31 | $41k | 2.4k | 17.13 |